CA1187798A - Protection des cellules - Google Patents

Protection des cellules

Info

Publication number
CA1187798A
CA1187798A CA000399231A CA399231A CA1187798A CA 1187798 A CA1187798 A CA 1187798A CA 000399231 A CA000399231 A CA 000399231A CA 399231 A CA399231 A CA 399231A CA 1187798 A CA1187798 A CA 1187798A
Authority
CA
Canada
Prior art keywords
chondroitin sulphate
chondroitin
damage
sulphate
endothelial
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA000399231A
Other languages
English (en)
Inventor
David B. Soll
Sol E. Harrison
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CA000399231A priority Critical patent/CA1187798A/fr
Application granted granted Critical
Publication of CA1187798A publication Critical patent/CA1187798A/fr
Expired legal-status Critical Current

Links

CA000399231A 1982-03-24 1982-03-24 Protection des cellules Expired CA1187798A (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA000399231A CA1187798A (fr) 1982-03-24 1982-03-24 Protection des cellules

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA000399231A CA1187798A (fr) 1982-03-24 1982-03-24 Protection des cellules

Publications (1)

Publication Number Publication Date
CA1187798A true CA1187798A (fr) 1985-05-28

Family

ID=4122386

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000399231A Expired CA1187798A (fr) 1982-03-24 1982-03-24 Protection des cellules

Country Status (1)

Country Link
CA (1) CA1187798A (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6083933A (en) * 1999-04-19 2000-07-04 Stellar International Inc. Treatment of cystitis-like symptoms with chondroitin sulfate following administration of a challenge solution
US7772210B2 (en) 2003-02-19 2010-08-10 Stellar Pharmaceuticals Inc. Cystitis treatment with high dose chondroitin sulfate

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6083933A (en) * 1999-04-19 2000-07-04 Stellar International Inc. Treatment of cystitis-like symptoms with chondroitin sulfate following administration of a challenge solution
US7772210B2 (en) 2003-02-19 2010-08-10 Stellar Pharmaceuticals Inc. Cystitis treatment with high dose chondroitin sulfate
US8084441B2 (en) 2003-02-19 2011-12-27 Stellar Pharmaceuticals, Inc. Cystitis treatment with high dose chondroitin sulfate
US8334276B2 (en) 2003-02-19 2012-12-18 Stellar Pharmaceuticals Inc. Cystitis treatment with high dose chondroitin sulfate
US8778908B2 (en) 2003-02-19 2014-07-15 Stellar International Inc. Cystitis treatment with high dose chondroitin sulfate

Similar Documents

Publication Publication Date Title
US4486416A (en) Protection of human and animal cells subject to exposure to trauma
US4971955A (en) Protection of human and animal cells during surgical trauma
EP0167363B1 (fr) Glycosaminoglycanes réticulés et leur utilisation
KR100307685B1 (ko) 눈의전방챔버에서축동제및산동제의조절방출법
US5792103A (en) Viscosurgical method and apparatus
Graue et al. The protective effect of Na-hyaluronate to corneal endothelium
JPH0121133B2 (fr)
US5141928A (en) Ophthalmic medication
US5103840A (en) Viscoelastic collagen gel for ophthalmic surgery
US5492936A (en) Bimodal molecular weight hyaluronate formulations and methods for using same
SK127099A3 (en) Controlled release of pharmaceuticals in the anterior chamber of the eye
US20100036387A1 (en) Viscoelastic Composition for Surgical Procedures
US5166048A (en) Protection of human corneal endothelial cells
JP3751017B2 (ja) 二頂分子量ヒアルロネート製剤およびその使用方法
Harrison et al. Chondroitin sulfate: a new and effective protective agent for intraocular lens insertion
US20200262985A1 (en) Transparent hydrogel membrane including hyaluronic acid, and contact lens including same
WO2006044155A2 (fr) Compositions ophtalmiques comprenant un lubrifiant, un agent deturgescent, ainsi qu'un glycosaminoglycane et methodes d'utilisation de ces dernieres
Soll et al. Evaluation and protection of corneal endothelium
WO1989000044A1 (fr) Larme artificielle
CA2470466C (fr) Combinaisons de produits viscoelastiques a l'usage de la chirurgie
CA1187798A (fr) Protection des cellules
Hoopes Sodium hyaluronate (Healon®) in anterior segment surgery: A review and a new use in extracapsular surgery
Arshinoff et al. HsS versus a balanced salt solution as a corneal wetting agent during routine cataract extraction and lens implantation
JPH0660200B2 (ja) 眼に使用するための粘弾性コラ−ゲン溶液
JPH0122248B2 (fr)

Legal Events

Date Code Title Description
MKEX Expiry